Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acorn Biolabs is a biotechnology company specializing in personalized regenerative medicine through the preservation of live hair follicle cells. The company provides a non-invasive method for individuals to bank their own young, healthy cells for future use in medical and aesthetic treatments. By leveraging cryopreservation technology, Acorn ensures that patients have access to their own high-quality biological material as they age, which can be used for applications ranging from skin rejuvenation to potential future cell-based therapies. Their platform bridges the gap between current preventative health and the future of regenerative medicine. The company currently partners with clinics to offer these services to consumers seeking long-term health and aesthetic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acorn Labs.